Trial Details

TERMINATED
Basic Information
Clinical ID c4564
Identifier NCT00316550
Trial Title Pilot Study to Assess the Effects of AV608 on Irritable Bowel Syndrome
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Irritable Bowel Syndrome (IBS)
Interventions DRUG: AV608
Participant Information
Sponsor Avera Pharmaceuticals
City Los Angeles
Country/Region United States
Enrollment Criteria
Sex Requirement FEMALE
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE1
Time Information
Start Date 2006-04
Primary Completion Date 2007-06
Completion Date 2007-09